PNTG insider filings

Pennant Group, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen PNTG transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 10 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Steik Jason Paul — Chief Clinical Officer1—1 leg · 218 sh · $8,098—
Gochnour John J — Chief Operating Officer1——3
SMITH BARRY M — Director2——2
COVEY STEPHEN M R — Director1——1
Christensen Christopher R. — Director1——1
Lamb Scott E — Director1——1
Morris Gregory K Sr. — Director1——1
Nackel John G. — Director1——1
Snapper Suzanne D. — Director1——1

Recent insider filings — Pennant Group, Inc.

FiledFormInsiderReported transactionsSource
2026-11-194Steik Jason Paul — Chief Clinical OfficerSale (S): 218 @ $37.15EDGAR
2026-11-134SMITH BARRY M — DirectorGift (G): 5,100 @ $36.74EDGAR
2026-10-274Gochnour John J — Chief Operating OfficerOption exercise (M): 5,948 @ $6.10 · Tax withholding (F): 6,624 @ $42.05 · Option exercise (M): 5,948 (derivative) @ $6.10EDGAR
2026-10-194Morris Gregory K Sr. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-10-194COVEY STEPHEN M R — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-10-194Lamb Scott E — DirectorGrant/award (A): 2,400 @ $0EDGAR
2026-10-194SMITH BARRY M — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-10-194Snapper Suzanne D. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-10-194Christensen Christopher R. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-10-194Nackel John G. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-08-104Steik Jason Paul — Chief Clinical OfficerSale (S): 1,394 @ $38.52EDGAR
2026-08-104Guerisoli Brent — Chief Executive OfficerSale (S): 4,285 @ $38.52EDGAR
2026-08-104Cheney Kirk Sterling — EVP, GC and Corp SecySale (S): 1,393 @ $38.52EDGAR
2026-07-174Morris Gregory K Sr. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-07-174Snapper Suzanne D. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-07-174Nackel John G. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-07-174Christensen Christopher R. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-07-174Lamb Scott E — DirectorGrant/award (A): 2,400 @ $0EDGAR
2026-07-174SMITH BARRY M — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-07-174COVEY STEPHEN M R — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-07-144Guerisoli Brent — Chief Executive OfficerOption exercise (M): 6,248 @ $4.54 · Sale (S): 3,159 @ $41.56 · Option exercise (M): 6,248 (derivative) @ $4.54EDGAR
2026-07-094Guerisoli Brent — Chief Executive OfficerOption exercise (M): 6,249 @ $4.54 · Sale (S): 3,165 @ $40.51 · Option exercise (M): 6,249 (derivative) @ $4.54EDGAR
2026-05-274Guerisoli Brent — Chief Executive OfficerOption exercise (M): 4,463 @ $3.84 · Sale (S): 22 @ $34.86 · Sale (S): 2,032 @ $35.08 · Sale (S): 200 @ $35.10 · Option exercise (M): 4,463 @ $3.84 · Sale (S): 2,254 @ $35.08 · +2 moreEDGAR
2026-04-174Morris Gregory K Sr. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-04-174/AGochnour John J — Chief Operating OfficerGrant/award (A): 11,214 @ $0 · Grant/award (A): 41,000 (derivative) @ $33.30EDGAR
2026-04-174/AGuerisoli Brent — Chief Executive OfficerGrant/award (A): 11,260 @ $0 · Grant/award (A): 45,000 (derivative) @ $33.30EDGAR
2026-04-174/ACheney Kirk Sterling — EVP, GC and Corp SecyGrant/award (A): 2,874 @ $0 · Grant/award (A): 30,000 (derivative) @ $33.30EDGAR
2026-04-174/AWalbom Lynette — Chief Financial OfficerGrant/award (A): 8,025 @ $0 · Grant/award (A): 34,000 (derivative) @ $33.30EDGAR
2026-04-174Snapper Suzanne D. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-04-174Nackel John G. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-04-174Christensen Christopher R. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-04-174Lamb Scott E — DirectorGrant/award (A): 2,400 @ $0EDGAR
2026-04-174SMITH BARRY M — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-04-174COVEY STEPHEN M R — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-03-124Cheney Kirk Sterling — EVP, GC and Corp SecyGrant/award (A): 4,085 @ $0 · Grant/award (A): 30,000 (derivative) @ $33.30EDGAR
2026-03-124Gochnour John J — Chief Operating OfficerGrant/award (A): 18,565 @ $0 · Grant/award (A): 41,000 (derivative) @ $33.30EDGAR
2026-03-124Walbom Lynette — Chief Financial OfficerGrant/award (A): 14,292 @ $0 · Grant/award (A): 34,000 (derivative) @ $33.30EDGAR
2026-03-124Steik Jason Paul — Chief Clinical OfficerGrant/award (A): 26,000 (derivative) @ $33.30EDGAR
2026-03-124Guerisoli Brent — Chief Executive OfficerGrant/award (A): 20,052 @ $0 · Grant/award (A): 45,000 (derivative) @ $33.30EDGAR
2026-01-214Morris Gregory K Sr. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-01-214Snapper Suzanne D. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-01-214Nackel John G. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-01-214Christensen Christopher R. — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-01-214Lamb Scott E — DirectorGrant/award (A): 2,400 @ $0EDGAR
2026-01-214SMITH BARRY M — DirectorGrant/award (A): 1,900 @ $0EDGAR
2026-01-214COVEY STEPHEN M R — DirectorGrant/award (A): 1,900 @ $0EDGAR
2025-11-134Cheney Kirk Sterling — EVP, GC and Corp SecyOption exercise (M): 3,800 @ $15.09 · Option exercise (M): 3,800 (derivative)EDGAR
2025-10-164Lamb Scott E — DirectorGrant/award (A): 2,400 @ $0EDGAR
2025-10-164SMITH BARRY M — DirectorGrant/award (A): 1,900 @ $0EDGAR
2025-10-164COVEY STEPHEN M R — DirectorGrant/award (A): 1,900 @ $0EDGAR

Recent 8-K events — Pennant Group, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-208-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-258-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-178-K/A9.01 — Financial Statements and ExhibitsEDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-058-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-028-K/A7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-028-K2.01 — Completion of Acquisition or Disposition of Assets
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PNTG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs